May 3, 2013 Regulatory Exclusivities and the Regulation of Generic Drugs and Biosimilars
Moderator: Benjamin Roin (Petrie-Flom Center)
Kate Greenwood (Seton Hall University School of Law), Calibrated Incentives for Orphan Drug Development: Time to Experiment?
Kevin Outterson (Boston University School of Law), Ending the Game of Shadows in Drug Regulation
Marie Boyd (University of South Carolina School of Law), Unequal Protection Under the Law: Reforming the Regulation of Generic Drugs
Henry Grabowski (Duke University), FDA Regulation of Biosimilars